Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 12NIH 4NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 34Lung Neoplasms 29Ovarian Neoplasms 23Carcinoma, Ovarian Epithelial 18Fallopian Tube Neoplasms 15Adenocarcinoma of Lung 14Neuroblastoma 13Central Nervous System Neoplasms 11Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 8Brain Neoplasms 8Brenner Tumor 7Adenocarcinoma, Bronchiolo-Alveolar 7Urinary Bladder Neoplasms 6Urethral Neoplasms 5Breast Neoplasms 5Astrocytoma 5Wilms Tumor 4Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Medulloblastoma 4Teratoma 3Radiation Injuries 3Optic Nerve Glioma 3Lymphoma 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Embryonal 3Carcinoma 3Thymoma 2

Interventions

Vincristine 17Cyclophosphamide 17Cytarabine 16Methotrexate 14Doxorubicin 14Prednisone 11Etoposide 11Radiotherapy 10merphos 9Rituximab 8Dexamethasone 8pegaspargase 7Leucovorin 7Filgrastim 7Calcium Dobesilate 7Methylprednisolone 6Daunorubicin 6dexamethasone acetate 5dexamethasone 21-phosphate 5calaspargase pegol 5azathiopurine 5auricularum 5Thioguanine 5Mercaptopurine 5Hydrocortisone 5Granulocyte Colony-Stimulating Factor 5Asparaginase 5prednylidene 4deltacortene 4Specimen Handling 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Burkitt Lymphoma × Carboplatin × Clear all
NCT00006708 2013-04-10

S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

SWOG Cancer Research Network

Phase 3 Terminated
7 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡